Aspirin De-Prescribing in Patients Taking Anticoagulants

The role of anticoagulant therapy (warfarin) with antiplatelet therapy (aspirin) is a balance of risk versus benefit. However, reducing risk by de-prescribing is often avoided due to hypothetical efficacy reduction. Join host, Geoff Wall, as he evaluates de-prescribing aspirin in patients taking anticoagulants.The GameChangerAnticoagulant therapy provides as good or better protection against vascular outcomes as aspirin – creating duplication of therapy. The increased risk of bleeds may not outweigh the negligible efficacy benefit.Are you looking for a place to network AND get some FREE CE?  Download the CEimpact app. The app allows you to connect with pharmacy professionals, get CE, attend events, access product information and so much more - all from your mobile device.Show Segments00:00 - Introductions00:58 - Aspirin Use with Anticoagulants4:02 - Overview of Schafer et al11:50 - The Gamechanger: Study Findings17:48 - Connecting to Practice: DOAC Use19:52 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesAssessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for AnticoagulationRedeem your CPE or CME hereCPE (Pharmacist)CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss indications for cardioprotective aspirin in patients taking anticoagulants2. Describe drawbacks to implementing the findings of the Schaefer et al study to a general patient population using anticoagulants0.05 CEU/0.5 HrUAN: 0107-0000-22-381-H01-PInitial release date: 10/24/2022Expiration date: 10/24/2023Additional CPE and CME details can be found hereFollow CEimpact on Social Media:LinkedInInstagram